Skip to Main Content

Paper Details

Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
Cancer Res
61
2017
C/EBP, DNA damage-inducible transcript 3, GADD153, GBM, GK921, GSC, Glioma, Glioma Stem Cells, MES, MES GBM, MES transcriptome, NF-B, STAT3, TAZ, TGM2, Transglutaminase 2, glioblastoma, glioma, glioma stem cells, mouse, patient, patients, sphere, transglutaminase 2, tumor
Author NameAffiliation
Sung Soo KimNational Cancer Center
Sung Soo KimNational Cancer Center
Hee Jin ChoSungkyunkwan University
Hee Jin ChoInstitute for Refractory Cancer Research, Samsung Medical Center
Jason K SaSungkyunkwan University
Jason K SaInstitute for Refractory Cancer Research, Samsung Medical Center
Ho-Shin GwakNational Cancer Center
Ho-Shin GwakResearch Institute and Hospital, National Cancer Center
Heon YooNational Cancer Center
Heon YooResearch Institute and Hospital, National Cancer Center
Seung Hoon LeeEulji University School of Medicine
Jeongwu LeeLerner Research Institute, Cleveland Clinic
Jong Heon KimNational Cancer Center
Jong Heon KimResearch Institute and Hospital, National Cancer Center
Do-Hyun NamSungkyunkwan University
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSungkyunkwan University
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Jong Bae ParkNational Cancer Center
Jong Bae ParkResearch Institute and Hospital, National Cancer Center
  • 1 - 22

Datasets

Release 1.2